Inhibition of VEGF release from tumor-associated macrophages in human lung cancer.
Inhibition of VEGF release from tumor-associated macrophages in human lung cancer.
批准号:
10671261
负责人:
TAKAHASHI Keiji
金额:
$2.05万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1998
资助国家:
日本
项目状态:
已结题
起止时间:
1998 至 1999
中文摘要
血管内皮生长因子(VEGF)的mRNA表达先前在多种肿瘤细胞中被证实,然而,还没有关于肿瘤相关巨噬细胞(TAM)释放VEGF的报道。在本研究中,研究了从原发性非小细胞肺癌新鲜分离的TAM是否具有释放VEGF的潜力。50%的非小细胞肺癌新鲜标本TAM中检测到VEGF 121和VEGF 165的mRNA表达。从1例肺癌患者分离的TAM中检测到VEGF 189 mRNA的表达。然而,我们没有检测到VEGF 206的mRNA表达。从80%的无淋巴结受累的肺癌患者中分离的TAM表达VEGF 121和VEGF 165的mRNA,而从有淋巴结受累的患者中分离的TAM既不表达VEGF 121也不表达VEGF 165的mRNA。在培养基中孵育3天期间,表达VEGF 121和VEGF 165的mRNA的浓度为105个细胞/ml的TAM释放的VEGF的量为3298.1 ± 3859 pg/ml,而不表达VEGF 121和VEGF 165 mRNA的TAM分泌量为3.8 ± 6.6pg/ml。我们的研究结果表明,TAM分泌的VEGF可能在非小细胞肺癌的血管生成和转移中起关键作用,在淋巴结受累发生之前。
英文摘要
Expression of mRNA for vascular endothelial growth factor (VEGF) previously demonstrated in a variety of tumor cells, however, there has been no report on VEGF release by tumor-associated macrophages (TAM). In the present study, whether TAM freshly separated from primary non-small cell lung cancer have a potential to release VEGF was investigated. The expressions of mRNA for both VEGF121 and VEGF165 were detected in TAM freshly separated from 50% of non-small cell lung cancer. The expression of mRNA for VEGF189 was detected in TAM separated from one lung cancer patient. However, we did not detect expression of mRNA for VEGF206. TAM separated from 80% of lung cancer patients without nodal involvement expressed mRNA for both VEGF121 and VEGF165, whereas TAM separated from patients with nodal involvement expressed neither mRNA for VEGF121 nor VEGF165. During 3 days' incubation in medium, the amount of VEGF released by TAM at a concentration of 105 cells/ml which expressed mRNA for VEGF121 and VEGF165 was 3298.1 ± 3859 pg/ml, whereas that secreted by TAM which expressed mRNA for neither VEGF121 nor VEGF165 was 3.8 ± 6.6 pg/ml.Our results indicated that VEGF secreted by TAM may play a key role in initiation of angiogenesis and metastasis in non-small cell lung cancer before nodal involvement occurs.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
INTERACTIONS BETWEEN ALVEOLAR TYPE II CELL AND CYTOKINES IN THE LUNG INJURY
-
批准号:07457151
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$4.74万
-
财政年份:1995
-
负责人:TAKAHASHI Keiji
-
依托单位:
Effects of Aging and Air Pollution on Development of Pulmonayr Fibrosis and Emphysema.
-
批准号:01480233
-
项目类别:Grant-in-Aid for General Scientific Research (B)
-
资助金额:$3.84万
-
财政年份:1989
-
负责人:TAKAHASHI Keiji
-
依托单位:
DEVELOPMENTAL MECHANISMS OF LUNG PARENCHYMAL INJURY EMPHYSEMA AND FIBROSI - CELL TO CELL INTERACTION IN LUNG PARENCHYMA -
-
批准号:62480201
-
项目类别:Grant-in-Aid for General Scientific Research (B)
-
资助金额:$1.92万
-
财政年份:1987
-
负责人:TAKAHASHI Keiji
-
依托单位:
国内基金
海外基金
登录
查看更多内容
协同靶向VE-PTP/VEGF重建胶质母细胞瘤血管稳态的双靶点抑制剂开发与机制研究
-
批准号:JCZRLH202601503
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
基于VEGF/VEGFR信号通路探讨自拟创疡膏对慢性创面的作用机制研究
-
批准号:2026JJ80680
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:姜平
-
依托单位:
Decorin调控ADAMTS12 m6A甲基化与IL12B/VEGF免疫互作介导肥胖合并妊娠期糖尿病子代心血管疾病的作用研究
-
批准号:2026JJ81694
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:罗慧
-
依托单位:
RNA 结合蛋白HuR与VEGF-D联合调控舌鳞癌侵袭及转移机制的研究
-
批准号:2026JJ80684
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:龚攀
-
依托单位:
金黄跌打散联合海桐皮汤通过HIF-1α/VEGF通路干预新生血管形成防治软骨损伤的机制研究
-
批准号:2026JJ81074
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:钟炜钰
-
依托单位:
基于蛋白质组学探究VEGF转染的人脐带间充质干细胞改善小鼠急性肝衰竭的机制及验证研究
-
批准号:2026JJ81849
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:陈海鸥
-
依托单位:
化痰通络汤调控PIEZO1/ACSL4/VEGF轴阻断线粒体机械转导增强内皮细胞铁死亡抗性促缺血性中风后血管新生的机制研究
-
批准号:2026JJ81884
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:朱新华
-
依托单位:
免疫微环境重塑驱动MAPK–VEGF-C/VEGFR-3信号轴调控巨噬细胞促淋巴管再生的机制研究
-
批准号:JCZRQNB202600447
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
IGF2BP2通过m6A甲基化修饰调控VEGF-C转录促进头颈鳞癌淋巴管生成的机制研究
-
批准号:JCZRQNB202600634
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
研究川崎病患者血清中VEGF水平与冠状动脉异常的相关性
-
批准号:2026JJ82691
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:鲁涛
-
依托单位: